Use access key #2 to skip to page content.
$2.43 0.92 (60.93%)
10/13/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar RBBioContest06 (47.70) Submitted: 5/31/06 10:43 PM : Outperform Start Price: $10.33 ACAD Score: -57.79

Picked by dockofthebay

Report this Post Replies: 0 | Reply

Featured Broker Partners